Many nations have taken the initiative to formulate the vaccine for the Coronavirus disease in 2019. Russia, UK, US, China, and India are the top countries that are actively developing a vaccine for the virus. Recent reports have claimed that a certain medical institute in Russia has completed all clinical trials for the vaccine they were developing.
The Sechenov First Moscow State Medical University in Moscow, Russia has reportedly seen positive results in their human clinical trials for the COVID-19 vaccine. The director of the university’s Institute for Translational Medicine and Biotechnology, Vadim Tarasov, confirmed the good news. The vaccine’s dosage form is lyophilized, meaning it’s a powder that needs to be dissolved in water for injection prior to administration via the intramuscular route.
Last June 18, the first stage of the clinical trial of the vaccine for human safety was performed on 18 volunteers. According to reliable sources, the group is set to be discharged on the 15th of July. The second stage of the trial was conducted on June 23, having injected 20 volunteers with the vaccine. Subjects developed immunity to the virus. The volunteers will still be monitored even after they are discharged.
This success implies that the vaccines that are already in the market are safe. The vaccine is yet to undergo the next phases of the clinical trial, and in reality, it still has quite a long way to go. The process for vaccine trials typically take years to complete, but with the ever-increasing number of cases worldwide, quick decisions need to be made and immediate actions have to be taken. And this is only one of the 17 vaccines that Russia is currently developing, according to their health minister. There is still no word as to when the mass productions will start and when distribution will begin but voluntary mass vaccinations are estimated to commence in August. The country now has more than 734,000 cases, with 11,439 deaths and 504,000 recoveries as of today.
India’s COVAXIN has just begun human trials. UK is under Phase III for the AstraZeneca and Oxford collaboration vaccine. The US has 2 vaccines under Phase 2, by Moderna and the other named Novavax. China has 4 vaccines under various stages of development. Germany’s candidate has reached Phase 2, and Australia is still under the first phase.